2746 A Phase 2 open-label, multicenter study of...

European Journal of Cancer 2015 / 09 Vol. 51

2746 A Phase 2 open-label, multicenter study of single-agent rucaparib in the treatment of patients with relapsed ovarian cancer and a deleterious BRCA mutation

Shapira-Frommer, R., Oza, A., Domchek, S.M., Balmana, J., Patel, M.R., Chen, L.M., Drew, Y., Burris, H.A., Korach, J., Flynn, M., Bowering, V.L., Morgan, M.A., Watkins, S.P., Simpson, D., Goble, S., M
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
51
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)31512-x
Date:
September, 2015
File:
PDF, 60 KB
english, 2015
Conversion to is in progress
Conversion to is failed